Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Mark Harper, who chairs the Covid Recovery Group of Tory MPs, said delivering vaccinations at pace “must become the central, overriding focus of government and I would encourage ministers to publish daily...
...This has rattled insurers and healthcare providers who have benefited from a sharp fall in the cost of treating high cholesterol as statins, such as Pfizer’s Lipitor, have lost patent protection in recent...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...What caused a stir was the designer’s low V-neck mermaid gown with bandeau accent, modified from her autumn show....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...The writers are co-authors of ‘Flash Foresight – How to See the Invisible and do the Impossible’ (Harper Business)...
...King Pharmaceuticals jumped 39 per cent, to $14.14, after rival Pfizer, the world’s biggest drugmaker, agreed to buy it for $3.6bn in an all-cash deal....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition